News & Analysis on Clinical Trial Services & Contract Research And Development
Outsourcing outfit, Oxford Genome Sciences and the University of Oxford have announced the development of new clinical biomarkers for colorectal cancer, which paves the way for a more personalised approach in treating this killer disease.
US packaging specialist, Comar, chose Interphex, New York, to launch its new custom design and production service for pharmaceutical packaging, offering customers a free initial consultation.
Scientists have made a remarkable discovery that could open up new avenues in drug development resulting in novel therapies for the treatment of poxviruses such as variola virus, the cause of smallpox.
Ablynx and Procter and Gamble have announced the extension of its Nanobody drug discovery and development agreement to metabolic targets in a move that reinforces the feeling within the industry regarding Nanobody technology and its potential.
After three acquisitions in two months, inVentiv Health has now expanded capacity in two of its divisions to meet the needs of its jump in client base.
Sigma-Aldrich launches an online tool consisting of data detailing biological pathways that provides an online resource to those in the drug industry interested in first-in-class range, including small molecules, antibodies, enzymes, QPCR components...
Olympus launches its latest screening station for the life science industry, in which the design aims to combine the modularity and flexibility of a microscope-based set-up with the automation and throughput of screening applications.